TIVC
Valion Bio, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.26
−10.46%Price chart
Jul 24Jul 29Aug 3Aug 6Aug 11Aug 14Aug 19Aug 24
Key dataAug 24, 2026
Open$0.12
From 52W high−91.95%
Volume109.75M
Market cap$340364.49
P/E (TTM)—
P/S (TTM)−2.2x
Div yield—
Key dataAug 24, 2026
Open
$0.12
From 52W high
−91.95%
Volume
109.75M
Market cap
$340364.49
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
P/E (TTM)
—
RSI (14)
33.8
MomentumView details →
1D Return
−10.46%
YTD Return
−88.55%
SummaryUpdated Jun 1, 2026
Tivic Health Systems, Inc. (NASDAQ:TIVC) is a bioelectronic medical device company founded in 2016 and headquartered in Hayward, California. The company went public in November 2021 and has undergone a significant strategic transformation from a single-product consumer device company to a diversified immunotherapeutics company. Originally focused on its ClearUP sinus relief device, Tivic has expanded its portfolio to include late-stage pharmaceutical assets and advanced bioelectronic therapies, positioning itself at the intersection of biologic and bioelectronic medicine for treating inflammatory and immune system disorders.
Similar companies
Latest newsMore news →
Valion Bio, Inc. appointed Dean Zikria to its Audit and Risk Committee, Compensation Committee and Nominations and Corporate Governance Committee effective September 22, 2026.26d agoValion Bio, Inc. appointed Jared Malbin as Chair of the Board's Audit and Risk Committee effective September 17, 2026.26d agoValion Bio, Inc. appointed Thomas Jensen as Chair of the Board and Chair of the Board's Compensation Committee effective September 17, 2026.26d ago